InvestorsHub Logo

oniwlmh

01/13/14 2:05 PM

#75973 RE: $heff #75909

ATHX... Sheff, I was hoping you could clarify some of the things surrounding a secondary offering. It seems like it would be dumb to buy the stock at the offering price of 4.10. Does that mean the company is going to have to cancel that offering and do another one at a lower price? Or was there already an agreement in place for people to buy the stock at the offering price when it was announced? Thanks for the help.

$heff

01/23/14 10:46 AM

#76433 RE: $heff #75909

BioPharmCatalyst updates: $AMAG PDUFA update due TODAY. FDA rejects $AMRN + $NKTR $KERX $VVUS $BLRX $AUXL http://t.co/ClWmgn9ugj

$heff

02/21/14 2:52 AM

#77761 RE: $heff #75909

$ALNY..Alnylam Pharmaceuticals Target Lifted to $94 at Needham & Company. http://streetinsider.com/r/9172126